Top compounds associated with response to MYEOV


Feature Type Standardized
Nominal ANOVA
mRNA FMK GDSC1000 pan-cancer AAC 0.07 0.08
mRNA RITA CTRPv2 pan-cancer AAC -0.066 0.08
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.059 0.08
mRNA GDC-0941 GDSC1000 pan-cancer AAC 0.062 0.08
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.08
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.08
mRNA WZ-1-84 GDSC1000 pan-cancer AAC 0.097 0.08
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.068 0.08
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.063 0.09
mRNA NSC-207895 GDSC1000 pan-cancer AAC -0.061 0.09
Download CSV